NEW YORK--(BUSINESS WIRE)--
Levi & Korsinsky announces it has commenced an investigation of Medtronic plc (“Medtronic” or the “Company”) (NYSE:MDT) concerning possible violations of federal securities laws.
On June 27, 2017, Medtronic filed its 10-K with the Securities and Exchange Commission, reporting a computer system crash that took place on June 19, 2017, and which affected the Company’s “ability to manufacture devices and fulfill orders from customers in a large portion of our business.” Then on July 17, 2017, an article featured on Bloomberg suggested that Medtronic CFO Karen Parkhill said the crash would “crimp quarterly sales.” Then on July 18, 2017, Medtronic filed an 8-K seeking to “clarify certain information contained in articles published” the day prior. The 8-K stated: “In an interview conducted and published with Bloomberg News, Karen Parkhill…confirmed that the Company continues to believe there will be no material impact from the disruption.” Medtronic also confirmed that “Given the IT disruption and strong new product demand in the Diabetes Group against a temporarily limited supply of sensors, the Company expects growth at the lower end of the range in the first quarter.” To obtain additional information, go to:
http://www.zlkdocs.com/MDT-Info-Request-Form-5952
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170719005826/en/
